News you can use about treatment and research breakthroughs

Visit Dr. Z's Medical Report

Cymbalta approved for fibromyalgia

Posted on June 19, 2008

The anti-depressant Cymbalta (duloxetine), marketed by Lilly, has received FDA approval for the treatment of fibromyalgia. While certain anti-depressants are considered first-line therapy for fibromyalgia, most notably the tricyclic anti-depressants such as amitriptyline, none had been approved by the FDA for this use until now. Cymbalta belongs to a newer class of anti-depressants known collectively as serotonin and norepinephrine reuptake inhibitors (SNRIs), which are somewhat similar to the serotonin reuptake inhibitors (SSRIs), of which Prozac, also marketed by Lilly, is the most widely k...

Original article link


anxiety , arthritis , constipation , depression , fibromyalgia , hearing , lupus , prozac , rheumatoid arthritis , sleep